Bioelectrical impedance analysis for sarcopenia: a systematic review and meta-analysis of diagnostic accuracy
Age and Ageing · 31.05.2025 · 54 (6)
DOI: 10.1093/ageing/afaf181 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Age and Ageing, online erschienen am 30.06.2025. Verfasst von Meng Luo und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rehabilitation Center, The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, China. Hauptthemen laut MEDLINE: Sarcopenia, Electric Impedance. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 77 Literaturangaben. Gefördert von: Ministry of Science and Technology of the People's Republic of China, Ministry of Science and Technology of the People’s Republic of China.
Abstract (Originalsprache)
Objective
To evaluate the diagnostic performance of bioelectrical impedance analysis (BIA) for detecting sarcopenia across diverse populations.
Methods
We conducted a search of MEDLINE, Embase, and Web of Science up to 2 January 2024. Cross-sectional, retrospective, and prospective cohort studies evaluating BIA’s diagnostic performance for detecting sarcopenia across diverse populations were included. The pooled sensitivity, specificity, positive and negative likelihood ratios (positive likelihood ratio [PLR] and negative likelihood ratio [NLR]), diagnostic odds ratio (DOR), and the area under the curve of summary receiver operating characteristic (SROC-AUC) were calculated using bivariate random-effects models. For each outcome, 95% confidence intervals (CI) were reported.
Results
A total of 27 studies involving 6239 participants were included. The pooled sensitivity was 79% (95% CI, 75%–82%), and the pooled specificity was 72% (95% CI, 68%–75%). The pooled PLR was 2.8 (95% CI, 2.5–3.1), the pooled NLR was 0.29 (95% CI, 0.25–0.35), and the pooled DOR was 9 (95% CI, 7–12). The SROC-AUC was 0.82 (95% CI, 0.78–0.85). Sensitivity analysis confirmed the robustness of these results. Heterogeneity was observed, which was attributable to variations in clinical and methodological factors.
Conclusions
This systematic review indicates that BIA has moderate diagnostic accuracy and practical clinical utility as a screening tool for sarcopenia, particularly in primary care and community settings. Further research is warranted to develop standardised protocols and predictive models to enhance consistency and reliability across populations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Rehabilitation Center, The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, China.
- The First Clinical Medical School, Henan University of Chinese Medicine, Zhengzhou, China.
- School of Rehabilitation Medicine, Henan University of Chinese Medicine, Zhengzhou, China.
Förderung
- Ministry of Science and Technology of the People's Republic of China
- Ministry of Science and Technology of the People’s Republic of China
Zitieren
APA
Luo, M., Duan, Z., Li, Y., Wang, Y., Chen, L., Gao, J., Wu, M., Sun, Y., Chen, L., & Feng, X. (2025). Bioelectrical impedance analysis for sarcopenia: a systematic review and meta-analysis of diagnostic accuracy. Age and Ageing, 54(6). https://doi.org/10.1093/ageing/afaf181
Vancouver
Luo M, Duan Z, Li Y, Wang Y, Chen L, Gao J, et al. Bioelectrical impedance analysis for sarcopenia: a systematic review and meta-analysis of diagnostic accuracy. Age and Ageing. 2025;54(6). doi:10.1093/ageing/afaf181
BibTeX
@article{Luo2025,
author = {Luo, Meng and Duan, Zhaoyuan and Li, Yunpeng and Wang, Yamin and Chen, Lulu and Gao, Jing and Wu, Mingli and Sun, Yalei and Chen, Lidian and Feng, Xiaodong},
title = {Bioelectrical impedance analysis for sarcopenia: a systematic review and meta-analysis of diagnostic accuracy},
journal = {Age and Ageing},
year = {2025},
volume = {54},
number = {6},
doi = {10.1093/ageing/afaf181}
}
EUVIMED